Targeting Stress Induction of GRP78 by Cardiac Glycoside Oleandrin Dually Suppresses Cancer and COVID-19

Overview

Journal Cell Biosci

Publisher Biomed Central

Specialty Biology

Date 2024 Sep 5

PMID 39238058

Authors

Dat P Ha

Woo-Jin Shin

Ze Liu

Michael E Doche

Roy Lau

Nektaria Maria Leli

Crystal S Conn

Mariangela Russo

Annalisa Lorenzato

Constantinos Koumenis

Min Yu

Shannon M Mumenthaler

Amy S Lee

Affiliations

Soon will be listed here.

Abstract

Background: Despite recent therapeutic advances, combating cancer resistance remains a formidable challenge. The 78-kilodalton glucose-regulated protein (GRP78), a key stress-inducible endoplasmic reticulum (ER) chaperone, plays a crucial role in both cancer cell survival and stress adaptation. GRP78 is also upregulated during SARS-CoV-2 infection and acts as a critical host factor. Recently, we discovered cardiac glycosides (CGs) as novel suppressors of GRP78 stress induction through a high-throughput screen of clinically relevant compound libraries. This study aims to test the possibility that agents capable of blocking stress induction of GRP78 could dually suppress cancer and COVID-19.

Results: Here we report that oleandrin (OLN), is the most potent among the CGs in inhibiting acute stress induction of total GRP78, which also results in reduced cell surface and nuclear forms of GRP78 in stressed cells. The inhibition of stress induction of GRP78 is at the post-transcriptional level, independent of protein degradation and autophagy and may involve translational control as OLN blocks stress-induced loading of ribosomes onto GRP78 mRNAs. Moreover, the human Na/K-ATPase α3 isoform is critical for OLN suppression of GRP78 stress induction. OLN, in nanomolar range, enhances apoptosis, sensitizes colorectal cancer cells to chemotherapeutic agents, and reduces the viability of patient-derived colon cancer organoids. Likewise, OLN, suppresses GRP78 expression and impedes tumor growth in an orthotopic breast cancer xenograft model. Furthermore, OLN blocks infection by SARS-CoV-2 and its variants and enhances existing anti-viral therapies. Notably, GRP78 overexpression mitigates OLN-mediated cancer cell apoptotic onset and suppression of virus release.

Conclusion: Our findings validate GRP78 as a target of OLN anti-cancer and anti-viral activities. These proof-of-principle studies support further investigation of OLN as a readily accessible compound to dually combat cancer and COVID-19.

References

Ha D, Tsai Y, Lee A . Suppression of ER-stress induction of GRP78 as an anti-neoplastic mechanism of the cardiac glycoside Lanatoside C in pancreatic cancer: Lanatoside C suppresses GRP78 stress induction. Neoplasia. 2021; 23(12):1213-1226. PMC: 8591401. DOI: 10.1016/j.neo.2021.10.004. View

Chen J, Lynn E, Yousof T, Sharma H, MacDonald M, Byun J . Scratching the Surface-An Overview of the Roles of Cell Surface GRP78 in Cancer. Biomedicines. 2022; 10(5). PMC: 9138746. DOI: 10.3390/biomedicines10051098. View

Lee A . GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res. 2007; 67(8):3496-9. DOI: 10.1158/0008-5472.CAN-07-0325. View

Newman R, Sastry K, Arav-Boger R, Cai H, Matos R, Harrod R . Antiviral Effects of Oleandrin. J Exp Pharmacol. 2020; 12:503-515. PMC: 7686471. DOI: 10.2147/JEP.S273120. View

Ni M, Zhou H, Wey S, Baumeister P, Lee A . Regulation of PERK signaling and leukemic cell survival by a novel cytosolic isoform of the UPR regulator GRP78/BiP. PLoS One. 2009; 4(8):e6868. PMC: 2729930. DOI: 10.1371/journal.pone.0006868. View

Hendershot L, Buck T, Brodsky J . The Essential Functions of Molecular Chaperones and Folding Enzymes in Maintaining Endoplasmic Reticulum Homeostasis. J Mol Biol. 2023; 436(14):168418. DOI: 10.1016/j.jmb.2023.168418. View

Su S, Chang Y, Andreu-Vieyra C, Fang J, Yang Z, Han B . miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer. Oncogene. 2012; 32(39):4694-701. PMC: 3787795. DOI: 10.1038/onc.2012.483. View

Tameire F, Verginadis I, Koumenis C . Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: Mechanisms and targets for therapy. Semin Cancer Biol. 2015; 33:3-15. PMC: 4523493. DOI: 10.1016/j.semcancer.2015.04.002. View

Smer-Barreto V, Quintanilla A, Elliott R, Dawson J, Sun J, Campa V . Discovery of senolytics using machine learning. Nat Commun. 2023; 14(1):3445. PMC: 10257182. DOI: 10.1038/s41467-023-39120-1. View

10.

Guo W, Wang M, Yang Z, Liu D, Ma B, Zhao Y . Recent advances in small molecule and peptide inhibitors of glucose-regulated protein 78 for cancer therapy. Eur J Med Chem. 2023; 261:115792. DOI: 10.1016/j.ejmech.2023.115792. View

11.

Garvey C, Spiller E, Lindsay D, Chiang C, Choi N, Agus D . A high-content image-based method for quantitatively studying context-dependent cell population dynamics. Sci Rep. 2016; 6:29752. PMC: 4958988. DOI: 10.1038/srep29752. View

12.

Yamamoto V, Wang B, Lee A . Suppression of head and neck cancer cell survival and cisplatin resistance by GRP78 small molecule inhibitor YUM70. Front Oncol. 2023; 12:1044699. PMC: 9875086. DOI: 10.3389/fonc.2022.1044699. View

13.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

14.

Gandhi S, Klein J, Robertson A, Pena-Hernandez M, Lin M, Roychoudhury P . De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report. Nat Commun. 2022; 13(1):1547. PMC: 8930970. DOI: 10.1038/s41467-022-29104-y. View

15.

Fu Y, Wey S, Wang M, Ye R, Liao C, Roy-Burman P . Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proc Natl Acad Sci U S A. 2008; 105(49):19444-9. PMC: 2614780. DOI: 10.1073/pnas.0807691105. View

16.

Shin W, Ha D, Machida K, Lee A . The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein. Nat Commun. 2022; 13(1):6551. PMC: 9663498. DOI: 10.1038/s41467-022-34065-3. View

17.

Huang C, Vishwanath S, Carnell G, Chan A, Heeney J . Immune imprinting and next-generation coronavirus vaccines. Nat Microbiol. 2023; 8(11):1971-1985. DOI: 10.1038/s41564-023-01505-9. View

18.

Zhang H, Qian D, Tan Y, Lee K, Gao P, Ren Y . Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci U S A. 2008; 105(50):19579-86. PMC: 2604945. DOI: 10.1073/pnas.0809763105. View

19.

Rayner J, Roberts R, Kim J, Poklepovic A, Roberts J, Booth L . AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication. Biochem Pharmacol. 2020; 182:114227. PMC: 7502229. DOI: 10.1016/j.bcp.2020.114227. View

20.

Iriondo O, Liu Y, Lee G, Elhodaky M, Jimenez C, Li L . TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis. Nat Commun. 2018; 9(1):1994. PMC: 5959931. DOI: 10.1038/s41467-018-04460-w. View